Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma

Clinical trial NCT00436800 · COMPLETED

Trial details

NCT number: NCT00436800
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Nasopharyngeal Neoplasms

Start date: 2005-03-01
Primary completion: 2008-10-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.